Search details
1.
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
J Hepatol
; 80(3): 431-442, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37972660
2.
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial.
Lancet
; 401(10389): 1655-1668, 2023 05 20.
Article
in English
| MEDLINE | ID: mdl-37068504
3.
Implementation of Precision Oncology in Clinical Practice: Results of a National Survey for Health Care Professionals.
Oncologist
; 28(6): e324-e330, 2023 06 02.
Article
in English
| MEDLINE | ID: mdl-36848261
4.
Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
BMC Cancer
; 23(1): 1006, 2023 Oct 19.
Article
in English
| MEDLINE | ID: mdl-37858207
5.
Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma-a retrospective, international, multicentric AGEO study.
Gastric Cancer
; 26(3): 425-437, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36881202
6.
Prognostic value of alkaline phosphatase and gamma-glutamyl transferase in patients with metastatic pancreatic cancer.
Future Oncol
; 19(13): 937-946, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-37232154
7.
Cost-effectiveness of poly-(ADP-ribose) polymerase (PARP)-inhibitors for the maintenance treatment after responding to first- and second-line chemotherapy in advanced ovarian cancer.
J Oncol Pharm Pract
; 29(2): 457-464, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36344039
8.
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol
; 23(7): 876-887, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35636444
9.
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based study.
Int J Cancer
; 151(8): 1310-1320, 2022 10 15.
Article
in English
| MEDLINE | ID: mdl-35723131
10.
Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab.
Oncologist
; 27(6): e484-e493, 2022 06 08.
Article
in English
| MEDLINE | ID: mdl-35429394
11.
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation.
Cancer Immunol Immunother
; 71(4): 865-874, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-34462870
12.
Risk Factors for Nab-Paclitaxel and Gemcitabine-Induced Peripheral Neuropathy in Patients with Pancreatic Cancer.
Oncology
; 100(7): 384-391, 2022.
Article
in English
| MEDLINE | ID: mdl-35551139
13.
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy.
Acta Oncol
; 60(10): 1317-1324, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-34282710
14.
Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand?
Gastric Cancer
; 24(4): 765-779, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33742317
15.
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 21(4): 497-507, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32164906
16.
Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer.
Int J Cancer
; 147(11): 3177-3188, 2020 12 01.
Article
in English
| MEDLINE | ID: mdl-32525595
17.
Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience.
Oncologist
; 25(12): e1996-e2005, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32557976
18.
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer.
Oncologist
; 25(8): 661-668, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32202020
19.
AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer.
BMC Cancer
; 20(1): 683, 2020 Jul 22.
Article
in English
| MEDLINE | ID: mdl-32698790
20.
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer.
Liver Int
; 40(3): 704-711, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31773848